Merit E. Cudkowicz, Md
Clinical trials sponsored by Merit E. Cudkowicz, Md, explained in plain language.
-
New drug tested in race to slow devastating ALS
Disease control CompletedThis study tested an investigational drug called DNL343 to see if it could slow the progression of ALS and improve survival. It involved 249 people with ALS who were randomly assigned to receive either the active drug or a placebo for 24 weeks. The main goals were to measure chan…
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC
-
New ALS drug shows promise in slowing disease
Disease control CompletedThis trial tested whether the drug ABBV-CLS-7262 could slow the progression of ALS (amyotrophic lateral sclerosis) and improve survival. It involved 310 people with ALS who were randomly assigned to receive either the drug or a placebo for 24 weeks. Researchers measured changes i…
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC